Pharmaceuticals in medicare reform
As policy makers explore ways to reform the Medicare system, the inevitable question of prescription drug coverage for the elderly will surface. This is an opportunity to revisit and balance the attractiveness of including a prescription benefit against the fear of increases in expenditures. Prudent...
Gespeichert in:
Veröffentlicht in: | Clinical therapeutics 1997-11, Vol.19 (6), p.1426-1432 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | As policy makers explore ways to reform the Medicare system, the inevitable question of prescription drug coverage for the elderly will surface. This is an opportunity to revisit and balance the attractiveness of including a prescription benefit against the fear of increases in expenditures. Prudent examination of the costs and benefits of prescription drug coverage requires looking beyond pharmaceutical product costs. |
---|---|
ISSN: | 0149-2918 1879-114X |
DOI: | 10.1016/S0149-2918(97)80016-1 |